SynthesisProstate cancer and prostatic diseases2022

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies.

Erik Margolis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.